Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
2008 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Biological markers for axonal degeneration in CSF and blood of patients with the first event indicative for multiple sclerosis
Hein (née Maier), K.; Köhler, A.; Diem, R. ; Sättler, M. B. ; Demmer, I. ; Lange, P. & Bähr, M. et al. (2008)
Neuroscience Letters, 436(1) pp. 72-76. DOI: https://doi.org/10.1016/j.neulet.2008.02.064
Documents & Media
Details
- Authors
- Hein (née Maier), K.; Köhler, A.; Diem, R. ; Sättler, M. B. ; Demmer, Iris ; Lange, P. ; Bähr, M. ; Otto, M.
- Abstract
- Axonal degeneration is now recognized as an important pathological feature of multiple sclerosis (MS). Acute axonal damage happens early in the disease course, and therefore early changes might occur in markers in body fluids, such as cerebrospinal fluid (CSF) and blood. In our study we investigated the relevance of serum and CSF markers for axonal damage in patients with clinically isolated syndrome indicative for MS. We measured the concentration of tau, phospho-tau, S100B, Amyloid beta and neuron specific enolase (NSE) in CSF and serum. Interestingly, the NSE concentration in CSF and serum was decreased in clinically isolated syndrome (CIS)-patients in comparison to the control group indicating reduced neuronal metabolic activity in the early stage of the disease. Concerning other biomarkers, we did not observe any changes in the concentrations between groups. Moreover, we did not detect any correlation between Expanded Disability Status Scale (EDSS) and the concentration of investigated proteins. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
- Issue Date
- 2008
- Journal
- Neuroscience Letters
- ISSN
- 0304-3940
- Language
- English